DJIA 16,643.01 -11.76 -0.07%
NASDAQ 4,828.33 15.62 0.32%
S&P 500 1,988.87 1.21 0.06%
market minute promo

0.32 0.02 (5.25%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

CYTX $0.32 5.25%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $0.34
Previous Close $0.30
Daily Range $0.29 - $0.34
52-Week Range $0.29 - $1.47
Market Cap $47.6M
P/E Ratio -0.88
Dividend (Yield) $0.00 (0.0%)
Volume 3,786,456
Average Daily Volume 1,308,728
Current FY EPS -$0.29

Sector

Healthcare

Industry

Drug Makers

Cytori Therapeutics, Inc. (USA) (CYTX) Description

A developing company which seeks to commercialize stem and regenerative cell therapies for cardiovascular disease, reconstructive surgery and many other serious, chronic, and life threatening conditions. Website: http://www.cytori.com/

News & Commentary

Fast and Furious Health Care Stocks This Week

MannKind, Cytori Therapeutics, and Omeros are among the health care stocks soaring this week.

Cytori Therapeutics (CYTX) Marc Hedrick onQ2 2015 Results - Earnings Call Transcript

Cytori Therapeutics (CYTX) Jumps: Stock Moves Up 10% - Tale of the Tape

Cytori Therapeutics (CYTX) Jumps: Stock Moves Up 10% - Tale of the Tape

Health Care Sector Update for 06/10/2015: IRWD, CYTX, HLS

Cytori Therapeutics' Preclinical Data for the Treatment of Thermal Injury Published in the Journal B

Cytori Therapeutics' Preclinical Data for the Treatment of Thermal Injury Published in the Journal Burns

Fluidigm Q1 Revenues Lower than Expected, Stock Down - Analyst Blog

Mettler-Toledo (MTD) Beats on Q1 Earnings, Sales; Stock Up - Analyst Blog

Ascendiant Capital Initiates Cytori Therapeutics With Buy

Benzinga's Top Initiations

Cytori Therapeutics (CYTX) Marc H. Hedrick on Q1 2015 Results - Earnings Call Transcript

Myriad Genetics Q3 Test Growth Impresses Yet Revenues Fall - Analyst Blog

See More CYTX News...

CYTX's Top Competitors

CYTX $0.32 (5.25%)
Current stock: CYTX
AMGN $155.89 (0.11%)
Current stock: AMGN
GILD $107.78 (-0.19%)
Current stock: GILD
BIIB $303.69 (-0.26%)
Current stock: BIIB